Xtl Biopharmaceuticals (XTLB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.96, +2.62% vs the prior close of $1.91.
- Volume 1.53K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
XTLB rises 2.6% to $1.96. Closed at $1.96, +2.62% vs the prior close of $1.91. Day range $1.94–$1.96, opened at $1.94.
XTLB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — XTLB rises 2.6% to $1.96
- Closed at $1.96, +2.62% vs the prior close of $1.91. Day range $1.94–$1.96, opened at $1.94.
- Volume was 1.53K shares, 0.2x its 50-day average of 8.86K — lighter than usual.
- Price is -19.1% vs its 50-day average ($2.42) and -28.9% vs its 200-day average ($2.76).
- 52-week range $1.86–$5.96; today's close sits at 2% of that range, 67.1% below the 52-week high.
Oct 15, 2026 — XTLB rises 1.6% to $1.91
- Closed at $1.91, +1.60% vs the prior close of $1.88. Day range $1.86–$2.01, opened at $1.86.
- Volume was 7.40K shares, 0.8x its 50-day average of 8.78K.
- Price is -21.7% vs its 50-day average ($2.44) and -30.8% vs its 200-day average ($2.76).
- 52-week range $1.86–$5.96; today's close sits at 1% of that range, 68.0% below the 52-week high.
Oct 14, 2026 — XTLB slides 5.1% to $1.88, a 52-week low
- Closed at $1.88, -5.05% vs the prior close of $1.98. Day range $1.86–$1.92, opened at $1.92.
- Volume was 2.20K shares, 0.2x its 50-day average of 9.02K — lighter than usual.
- Price is -23.5% vs its 50-day average ($2.46) and -32.0% vs its 200-day average ($2.77).
- 52-week range $1.86–$6.24; today's close sits at 0% of that range, 69.9% below the 52-week high.
- SEC filings that day: 6-K.
Oct 13, 2026 — XTLB jumps 3.1% to $1.98
- Closed at $1.98, +3.13% vs the prior close of $1.92. Day range $1.88–$1.98, opened at $1.93.
- Volume was 4.30K shares, 0.5x its 50-day average of 9.02K — lighter than usual.
- Price is -20.1% vs its 50-day average ($2.48) and -28.5% vs its 200-day average ($2.77).
- 52-week range $1.88–$6.24; today's close sits at 2% of that range, 68.3% below the 52-week high.
Oct 12, 2026 — XTLB slides 3.0% to $1.92, a 52-week low
- Closed at $1.92, -3.03% vs the prior close of $1.98. Day range $1.92–$1.95, opened at $1.95.
- Volume was 1.60K shares, 0.2x its 50-day average of 9.02K — lighter than usual.
- Price is -23.1% vs its 50-day average ($2.50) and -30.8% vs its 200-day average ($2.78).
- 52-week range $1.92–$6.48; today's close sits at 0% of that range, 70.4% below the 52-week high.
Oct 9, 2026 — XTLB dips 0.5% to $1.98
- Closed at $1.98, -0.50% vs the prior close of $1.99. Day range $1.98–$2.03, opened at $1.98.
- Volume was 8.80K shares, 1.0x its 50-day average of 8.92K.
- Price is -21.3% vs its 50-day average ($2.51) and -28.8% vs its 200-day average ($2.78).
- 52-week range $1.97–$7.44; today's close sits at 0% of that range, 73.4% below the 52-week high.
Oct 8, 2026 — XTLB rises 0.5% to $1.99
- Closed at $1.99, +0.51% vs the prior close of $1.98. Day range $1.97–$2.03, opened at $1.98.
- Volume was 13.60K shares, 1.6x its 50-day average of 8.69K.
- Price is -21.4% vs its 50-day average ($2.53) and -28.6% vs its 200-day average ($2.79).
- 52-week range $1.97–$10.28; today's close sits at 0% of that range, 80.6% below the 52-week high.
Oct 7, 2026 — XTLB dips 2.0% to $1.98, a 52-week low on 3.4x normal volume
- Closed at $1.98, -1.98% vs the prior close of $2.02. Day range $1.98–$2.05, opened at $2.02.
- Volume was 27.80K shares, 3.4x its 50-day average of 8.26K — unusually heavy trading.
- Price is -22.4% vs its 50-day average ($2.55) and -29.2% vs its 200-day average ($2.80).
- 52-week range $1.98–$10.28; today's close sits at 0% of that range, 80.7% below the 52-week high.
Oct 6, 2026 — XTLB slides 7.3% to $2.02, a 52-week low on 4.9x normal volume
- Closed at $2.02, -7.34% vs the prior close of $2.18. Day range $2.02–$2.26, opened at $2.17.
- Volume was 37.00K shares, 4.9x its 50-day average of 7.54K — unusually heavy trading.
- Price is -21.4% vs its 50-day average ($2.57) and -27.9% vs its 200-day average ($2.80).
- 52-week range $2.01–$10.28; today's close sits at 0% of that range, 80.4% below the 52-week high.
Oct 5, 2026 — XTLB rises 0.9% to $2.18
- Closed at $2.18, +0.93% vs the prior close of $2.16. Day range $2.17–$2.36, opened at $2.20.
- Volume was 12.90K shares, 1.8x its 50-day average of 7.31K.
- Price is -15.8% vs its 50-day average ($2.59) and -22.3% vs its 200-day average ($2.81).
- 52-week range $2.01–$10.28; today's close sits at 2% of that range, 78.8% below the 52-week high.
Oct 2, 2026 — XTLB rises 1.4% to $2.16
- Closed at $2.16, +1.41% vs the prior close of $2.13. Day range $2.16–$2.21, opened at $2.17.
- Volume was 6.70K shares, 0.9x its 50-day average of 7.31K.
- Price is -17.0% vs its 50-day average ($2.60) and -23.2% vs its 200-day average ($2.81).
- 52-week range $2.01–$10.28; today's close sits at 2% of that range, 79.0% below the 52-week high.
XTLB latest news & SEC filings
Every SEC filing by or about XTLB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 5, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 21, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 30, 2026 · Form 20-F — Annual report from a foreign company (20-F)
Annual report from a foreign company (20-F)
Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).
Jun 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 23, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade XTLB
- How much it moves: over the last 20 sessions the average daily move was 3.42% (largest 9.5%). That is a volatile stock.
- Liquidity: about 8.89K shares (≈$17.42K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.96 vs a range of $1.86–$5.96 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:4 on Mar 25, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 14, 2026; 6-K Aug 5, 2026; 6-K Jul 21, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
XTLB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.94 | 1.96 | 1.94 | 1.96 | 1.53K |
| Oct 15, 2026 | 1.86 | 2.01 | 1.86 | 1.91 | 7.40K |
| Oct 14, 2026 | 1.92 | 1.92 | 1.86 | 1.88 | 2.20K |
| Oct 13, 2026 | 1.93 | 1.98 | 1.88 | 1.98 | 4.30K |
| Oct 12, 2026 | 1.95 | 1.95 | 1.92 | 1.92 | 1.60K |
| Oct 9, 2026 | 1.98 | 2.03 | 1.98 | 1.98 | 8.80K |
| Oct 8, 2026 | 1.98 | 2.03 | 1.97 | 1.99 | 13.60K |
| Oct 7, 2026 | 2.02 | 2.05 | 1.98 | 1.98 | 27.80K |
| Oct 6, 2026 | 2.17 | 2.26 | 2.02 | 2.02 | 37.00K |
| Oct 5, 2026 | 2.20 | 2.36 | 2.17 | 2.18 | 12.90K |
| Oct 2, 2026 | 2.17 | 2.21 | 2.16 | 2.16 | 6.70K |
| Oct 1, 2026 | 2.42 | 2.42 | 2.13 | 2.13 | 7.10K |
| Sep 30, 2026 | 2.33 | 2.33 | 2.30 | 2.30 | 1.60K |
| Sep 29, 2026 | 2.26 | 2.28 | 2.11 | 2.21 | 24.30K |
| Sep 28, 2026 | 2.27 | 2.44 | 2.23 | 2.23 | 3.60K |
| Sep 25, 2026 | 2.30 | 2.43 | 2.20 | 2.20 | 1.00K |
| Sep 24, 2026 | 2.22 | 2.50 | 2.22 | 2.41 | 13.10K |
| Sep 23, 2026 | 2.39 | 2.40 | 2.20 | 2.20 | 2.50K |
| Sep 22, 2026 | 2.38 | 2.38 | 2.38 | 2.38 | 0 |
| Sep 21, 2026 | 2.27 | 2.38 | 2.19 | 2.38 | 700 |
About Xtl Biopharmaceuticals
Xtl Biopharmaceuticals (XTLB) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NEW YORK, NY. State of incorporation: Israel. Fiscal year ends —. SEC CIK 1023549.
XTLB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Fain Osnat Hillel | Director | Mar 23, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
XTLB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
XTLB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on XTLB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.